Coronavirus Cases in India: The recovery rate is 96.19 percent. New Delhi: Nearly 56 million people in England will return to a total coronavirus lockdown, possibly until mid-February, to try to reduce spiraling infection rates, Prime Minister Boris Johnson said on Monday. The measures, which include the closure of primary …
Read More »Ahmedabad begins online registration. Who can do it?
A ‘safe and effective’ vaccine against the new coronavirus could soon become a reality. India has already started the registration process to distribute the vaccine as soon as it is available. Ahmedabad Municipal Corporation launched an online portal for vaccination registration on Saturday, news agency PTI reported. The coronavirus vaccine …
Read More »Covid Shot Voluntary, Says Government, Lists Standard Operating Procedures for Vaccination
The Ministry of Health said that the COVID-19 vaccine will be voluntary, but registration is mandatory New Delhi: Getting vaccinated against COVID-19 will be voluntary, the Union Health Ministry said, while stressing that the vaccine introduced in India will be as effective as any vaccine developed by other countries. The …
Read More »Covid-19 Vaccine Update: Pfizer Seeks Emergency Use Approval in India, UK Launches Inoculation Plan
After obtaining clearance for emergency use in the UK and Bahrain, Pfizer Inc has applied for emergency use authorization in India. The UK is preparing for the emergency launches of the Pfizer vaccine and is now in the final planning stages before the vaccination campaign begins on December 14. In …
Read More »As wealthy nations hoard vaccines, the fight against Covid could extend into 2024
The good results of the Pfizer vaccine have spread joy throughout the world. Some other vaccines also look promising, and large-scale vaccination of at least health workers and others at risk could begin soon. However, experts say it could take four years to immunize the world against the coronavirus. This …
Read More »Serum Institute of India begins manufacturing Codagenix COVID-19 nasal vaccine
Serum Institute of India has begun manufacturing the COVID-19 candidate vaccine developed by Codagenix Inc, the American biotech firm said in a statement. Nicknamed CDX-005, the coronavirus vaccine candidate has completed preclinical studies in animals. The company aims to begin the phase I clinical trial of its COVID-19 vaccine in …
Read More »